Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alphabet A | GOOGL | Nov 27, 2024 | 169.23 | +0.07 |
Alphabet C | GOOG | Nov 27, 2024 | 170.82 | +0.12 |
AlphaMark Actively Managed Small Cap ETF | SMCP | Nov 27, 2024 | 35.40 | -0.01 |
Alphatec | ATEC | Nov 27, 2024 | 10.37 | +7.91 |
AlphaTime Acquisition | ATMC | Nov 27, 2024 | 11.31 | 0.00 |
AlphaVest Acquisition | ATMV | Nov 27, 2024 | 11.25 | 0.00 |
AlphaVest Acquisition Unit | ATMVU | Nov 27, 2024 | 11.31 | 0.00 |
Alpine Income Property | PINE | Nov 27, 2024 | 17.98 | -0.11 |
Alps Alerian MLP ETF | AMLP | Nov 27, 2024 | 50.31 | +1.33 |
Alps Equal Sector Weight ETF | EQL | Nov 27, 2024 | 132.69 | -0.08 |
Alps International Sector Divid | IDOG | Nov 27, 2024 | 29.20 | +0.41 |
Alps Sector Dividend Dogs ETF | SDOG | Nov 27, 2024 | 60.95 | -0.16 |
Alset EHome International | AEI | Nov 27, 2024 | 1.21 | +12.04 |
Alt5 Sigma | ALTS | Nov 27, 2024 | 2.26 | +5.12 |
Alta Equipment A Pref | ALTG-A | Nov 27, 2024 | 25.81 | +1.03 |
Alta Equipment Group A | ALTG | Nov 27, 2024 | 7.74 | -3.85 |
Alta Global Group | MMA | Nov 27, 2024 | 1.78 | -1.66 |
Altair Engineering A | ALTR | Nov 27, 2024 | 105.42 | +0.02 |
Altamira Therapeutics | CYTO | Nov 27, 2024 | 0.40 | -4.49 |
AltEnergy Acquisition A | AEAE | Nov 27, 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Nov 27, 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Nov 27, 2024 | 1.09 | +2.83 |
Alternus Clean Energy A | ALCE | Nov 27, 2024 | 1.24 | -4.61 |
Alti Global A | ALTI | Nov 27, 2024 | 4.55 | +4.84 |
Altice USA A | ATUS | Nov 27, 2024 | 2.60 | +3.59 |
Altimmune | ALT | Nov 27, 2024 | 8.73 | +3.56 |
Altisource Portfolio Solutions | ASPS | Nov 27, 2024 | 0.94 | +11.63 |
Alto Ingredients | ALTO | Nov 27, 2024 | 1.48 | +4.96 |
Alto Neuroscience | ANRO | Nov 27, 2024 | 4.28 | -1.15 |
Altria Group | MO | Nov 27, 2024 | 57.65 | +0.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.